| Eculizumab and recurrent C3 glomerulonephritis S Gurkan, B Fyfe, L Weiss, X Xiao, Y Zhang, RJ Smith Pediatric Nephrology 28, 1975-1981, 2013 | 108 | 2013 |
| C3 glomerulopathy: the genetic and clinical findings in dense deposit disease and C3 glomerulonephritis X Xiao, MC Pickering, RJH Smith Seminars in thrombosis and hemostasis, 465-471, 2014 | 68 | 2014 |
| A mechanism for synergy with combined mTOR and PI3 kinase inhibitors S Yang, X Xiao, X Meng, KK Leslie PloS one 6 (10), e26343, 2011 | 64 | 2011 |
| A novel hybrid CFHR1/CFH gene causes atypical hemolytic uremic syndrome SJ Eyler, NC Meyer, Y Zhang, X Xiao, CM Nester, RJH Smith Pediatric nephrology 28, 2221-2225, 2013 | 59 | 2013 |
| Familial C3 glomerulonephritis caused by a novel CFHR5-CFHR2 fusion gene X Xiao, C Ghossein, A Tortajada, Y Zhang, N Meyer, M Jones, NG Borsa, ... Molecular immunology 77, 89-96, 2016 | 53 | 2016 |
| Epigenetic modification restores functional PR expression in endometrial cancer cells S Yang, X Xiao, Y Jia, X Liu, Y Zhang, X Wang, C J Winters, E J Devor, ... Current pharmaceutical design 20 (11), 1874-1880, 2014 | 46 | 2014 |
| A novel fusion gene CHFR5–CFHR2 causes C3 Glomerulonephritis Y Zhang, X Xiao, J Garcia-Fernandez, SR de Cordoba, P Zipfel, N Meyer, ... Molecular immunology 56 (3), 297-297, 2013 | 5 | 2013 |
| Modeling C3 glomerulopathies: C3 convertase regulation on an extracellular matrix surface S Pisarenka, NC Meyer, X Xiao, R Goodfellow, CM Nester, Y Zhang, ... Frontiers in immunology 13, 1073802, 2023 | 1 | 2023 |
| Combination therapy with mTOR and PI3 kinase inhibitors is broadly synergistic in a wide variety of endometrial cancer cells S Yang, X Xiao, X Meng, KK Leslie Cancer Research 71 (8_Supplement), 5368-5368, 2011 | 1 | 2011 |
| Assembly and regulation of C3 convertase on the surface of an in vitro model of glycomatrix S Pisarenka, X Xiao, Y Zhang, R Smith MOLECULAR IMMUNOLOGY 141, 128-128, 2022 | | 2022 |
| IN VITRO MODELING OF THE GLYCOMATRIX TO STUDY KINETICS OF C3 CONVERTASE S Pisarenka, X Xiao, Y Zhang, R Smith MOLECULAR IMMUNOLOGY 114, 435-435, 2019 | | 2019 |
| GENETIC ALTERATIONS OF THE GLYCOMATRIX IN C3 GLOMERULOPATHY J Hauer, F Bu, X Xiao, K Frees, NG Borsa, A Taylor, C Nester, R Smith MOLECULAR IMMUNOLOGY 114, 422-423, 2019 | | 2019 |
| C3 glomerulopathy: exploring the role of the glomerular micro-environment in disease pathogenesis X Xiao The University of Iowa, 2017 | | 2017 |
| Unraveling the role of the glomerular glycomatrix in C3 glomerulopathy J Hauer, FX Bu, X Xiao, K Frees, NG Borsa, A Taylor, P Breheny, ... Molecular Immunology 89, 183-183, 2017 | | 2017 |
| Is CFHR3-CFHR1 copy number variation associated with C3 glomerulopathy M Jones, N Meyer, X Xiao, C Nester, R Smith MOLECULAR IMMUNOLOGY 67 (1), 149-149, 2015 | | 2015 |
| Soluble CR1 Gene therapy corrects renal phenotypes in a murine model of C3G X Xiao, Y Zhang, J Staber, S Sethi, P McCray, C Nester, R Smith MOLECULAR IMMUNOLOGY 67 (1), 195-196, 2015 | | 2015 |
| Epigenetic modulation restores expression of functional progesterone receptor in endometrial cancer cells S Yang, X Xiao, Y Zhang, X Meng, KK Leslie Cancer Research 72 (8_Supplement), 4711-4711, 2012 | | 2012 |
